Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug
The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.
Tribune News Service ·